Viewing Study NCT01212705


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-01-01 @ 2:36 AM
Study NCT ID: NCT01212705
Status: UNKNOWN
Last Update Posted: 2010-10-01
First Post: 2010-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Adaptive Servoventilation on Cardiac Function in Chronic Heart Failure and Cheyne-Stokes Respiration
Sponsor: Military Institute od Medicine National Research Institute
Organization:

Study Overview

Official Title: Effect of Adaptive Servoventilation on Cardiac Function, Exercise Tolerance and Quality of Life in Patients With Chronic Heart Failure and Cheyne-Stokes Respiration
Status: UNKNOWN
Status Verified Date: 2010-09
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Sleep disordered breathing is common in patients with chronic heart failure. Adaptive servoventilation is a novel method of treatment central sleep apnoea, especially associated with Cheyne-Stokes-respiration. The aim of the study is to investigate effect of adaptive servoventilation on cardiac function, exercise tolerance and quality of life in patients with chronic heart failure.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: